BioRestorative Therapies (BRTX) Projected to Post Earnings on Wednesday

BioRestorative Therapies (NASDAQ:BRTX) is projected to issue its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 14th. Analysts expect the company to announce earnings of ($0.32) per share and revenue of $0.38 million for the quarter.

BioRestorative Therapies (NASDAQ:BRTX) last announced its quarterly earnings data on Thursday, March 27th. The company reported ($0.20) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.07. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The business had revenue of $0.50 million for the quarter, compared to the consensus estimate of $0.48 million. On average, analysts expect BioRestorative Therapies to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

BioRestorative Therapies Stock Down 1.1%

Shares of BioRestorative Therapies stock opened at $1.80 on Monday. The stock’s 50-day simple moving average is $1.74 and its 200-day simple moving average is $1.75. BioRestorative Therapies has a 52 week low of $1.03 and a 52 week high of $2.55. The company has a market capitalization of $13.51 million, a price-to-earnings ratio of -1.18 and a beta of 77.73.

BioRestorative Therapies Company Profile

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.